Mutations and deletions within the hepatitis B virus core antigen and locations of B cell recognition sites

ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing.

Immuno-oncology technology·2022

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.

Human vaccines & immunotherapeutics·2019

Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure.

Alimentary pharmacology & therapeutics·2015

Identification of galactose-α-1,3-galactose in the gastrointestinal tract of the tick Ixodes ricinus; possible relationship with red meat allergy.

Allergy·2013

Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.

Gene therapy·2010

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.

Gut·2008

The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infection.

The Journal of infectious diseases·2026

Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis.

The Journal of infectious diseases·2026

Population-level shift in ex vivo artemisinin susceptibility in Plasmodium falciparum: comparison of 2014-2015 and 2022-2024 surveys in northern Uganda.

The Journal of infectious diseases·2026

Carbapenemase-producing Kluyvera spp.: epidemiology of an evolving species.

The Journal of infectious diseases·2026

Low birthweight and prematurity, but not malaria chemoprevention, are associated with reduced pneumococcal vaccine immunogenicity in Ugandan infants.

The Journal of infectious diseases·2026

Expert Consensus on Controlled Human Infection Studies for Gonorrhoea.

The Journal of infectious diseases·2026

Lactate-Depleting Nanotherapy Reprograms the Immunometabolic Microenvironment to Overcome Biofilm Tolerance in Implant-Associated Infections.

Advanced materials (Deerfield Beach, Fla.)·2026

Baseline and Longitudinal Pan-Immune-Inflammation Value Compared with Other Inflammatory Indices in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort Study.

Sisli Etfal Hastanesi tip bulteni·2026

Ocular immune homeostasis-mechanisms of precise regulation through coordination of the eye, visual system and beyond: a narrative review.

Annals of eye science·2026

Dynamic neutrophil-to-lymphocyte ratio as an independent prognostic marker of overall survival in patients receiving immune checkpoint inhibitors: a Latin American cohort study.

Frontiers in oncology·2026

Early Clinical Warning Signs of Inborn Errors of Immunity in the Neonatal Intensive Care Unit: A Retrospective Observational Study.

Sisli Etfal Hastanesi tip bulteni·2026

Immunological dynamics of memory T cells in gram-negative septic shock patients: a prospective clinical study.

Frontiers in immunology·2026

Related Experiment Videos

Mutations and deletions within the hepatitis B virus core antigen and locations of B cell recognition sites

Related Concept Videos

ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing.

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.

Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure.

Identification of galactose-α-1,3-galactose in the gastrointestinal tract of the tick Ixodes ricinus; possible relationship with red meat allergy.

Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.

The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infection.

Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis.

Population-level shift in ex vivo artemisinin susceptibility in Plasmodium falciparum: comparison of 2014-2015 and 2022-2024 surveys in northern Uganda.

Carbapenemase-producing Kluyvera spp.: epidemiology of an evolving species.

Low birthweight and prematurity, but not malaria chemoprevention, are associated with reduced pneumococcal vaccine immunogenicity in Ugandan infants.

Expert Consensus on Controlled Human Infection Studies for Gonorrhoea.

Lactate-Depleting Nanotherapy Reprograms the Immunometabolic Microenvironment to Overcome Biofilm Tolerance in Implant-Associated Infections.

Baseline and Longitudinal Pan-Immune-Inflammation Value Compared with Other Inflammatory Indices in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort Study.

Ocular immune homeostasis-mechanisms of precise regulation through coordination of the eye, visual system and beyond: a narrative review.

Dynamic neutrophil-to-lymphocyte ratio as an independent prognostic marker of overall survival in patients receiving immune checkpoint inhibitors: a Latin American cohort study.

Early Clinical Warning Signs of Inborn Errors of Immunity in the Neonatal Intensive Care Unit: A Retrospective Observational Study.

Immunological dynamics of memory T cells in gram-negative septic shock patients: a prospective clinical study.

Related Experiment Videos

Mutations and deletions within the hepatitis B virus core antigen and locations of B cell recognition sites

Related Concept Videos

Related Articles